Pricing
Nightbox — pre-clinical biotech компания. Lead asset (NKG2D-LIF6) — не commercialized — продаётся как продукт. Pricing относится к R&D services + IP licensing + open-source tooling.
Therapeutic products
NKG2D-LIF6 chimera — pre-clinical, не commercially available. Clinical timeline на /ru/roadmap. Pre-IND H2 2026, IND filing 2027-2028.
IP licensing (post-IND)
Provisional patent в работе. License terms TBD после IND filing. Inquiries: partnerships@nightboxllc.com
Open-source tooling
UniGPU runtime
Vendor-neutral GPU compute abstraction. Source: github.com/nightbox-llc
SilverDuck local-first AI agent
Local-first multi-agent stack с persistent memory + SDPC encrypted cloud handoff.
Quack programming language
Multi-lingual programming language (9 languages, 364 keywords). Source open.
Doctrines + manifests
Liaison Framework, Market Re-Entry Roadmap, all .well-known/ manifests. Anyone can fork и adapt for their jurisdiction.
Custom R&D services
Custom computational biology, freedom-to-operate scanning, regulatory consulting, federal SBIR proposal review. Hourly rates + retainer structures. Inquiries: artem@nightboxllc.com
Investor inquiries
Pre-seed round Q3 2026 ($3M-$5M target). Details: /ru/investors